Nu Skin Enterprises Inc (NUS) financial statements: income statement, balance sheet and cash flow
Nu Skin Enterprises Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Nu Skin Enterprises Inc reported revenue of $1.5B (-14.3% year on year) and net income of $160.2M (+209.3% year on year).
Income statement
Nu Skin Enterprises Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenue
$1.5B
$1.7B
$2.0B
$2.2B
Cost of sales
$453.8M
$550.2M
$611.9M
$630.9M
Gross profit
$1.0B
$1.2B
$1.4B
$1.6B
Selling expenses
$508.4M
$652.0M
$742.4M
$879.6M
General and administrative expenses
$432.1M
$479.0M
$546.9M
$555.8M
Restructuring and impairment expenses
$25.1M
$202.4M
$19.8M
$48.5M
Total operating expenses
$965.6M
$1.3B
$1.3B
$1.5B
Operating income (loss)
$65.8M
($151.6M)
$48.3M
$110.8M
Interest expense
$13.9M
$26.4M
—
—
Gain on sale
$176.2M
—
—
—
Other income (expense), net
($31.8M)
$2.9M
($21.7M)
($21.9M)
Income (loss) before provision for income taxes
$196.2M
($175.1M)
$26.6M
$89.0M
Provision (benefit) for income taxes
$36.0M
($28.5M)
$18.0M
($15.8M)
Net income (loss)
$160.2M
($146.6M)
$8.6M
$104.8M
Basic (in dollars per share)
$3.25
-$2.95
$0.17
$2.10
Diluted (in dollars per share)
$3.18
-$2.95
$0.17
$2.07
Basic (in shares)
49.3M
49.7M
49.7M
50.0M
Diluted (in shares)
50.3M
49.7M
49.9M
50.5M
Nu Skin Enterprises Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenue
$320.1M
$320.6M
$364.2M
$386.1M
Cost of sales
$101.8M
$106.1M
$107.5M
$120.4M
Gross profit
$218.3M
$214.5M
$256.7M
$265.7M
Selling expenses
$107.9M
$110.1M
$130.3M
$128.2M
General and administrative expenses
$90.8M
$98.5M
$104.8M
$106.7M
Impairment expenses
$78.9M
$1.8M
—
—
Total operating expenses
$277.6M
$210.4M
$235.1M
$235.0M
Operating income (loss)
($59.3M)
$4.0M
$21.6M
$30.8M
Interest expense
$3.3M
$4.3M
$4.1M
$2.5M
Gain on sale of business
$0
$0
$0
$0
Other income (expense), net
($534.0K)
$2.8M
($1.5M)
($843.0K)
Income (loss) before provision for income taxes
($63.2M)
$2.6M
$16.0M
$27.4M
Provision for income taxes
$186.6M
$763.0K
($1.1M)
$6.3M
Net income (loss)
($249.8M)
$1.8M
$17.1M
$21.1M
Basic (in Dollars per share)
-$5.14
$0.04
$0.35
$0.43
Diluted (in Dollars per share)
-$5.14
$0.04
$0.34
$0.43
Basic (in Shares)
48.6M
48.2M
49.4M
49.4M
Diluted (in Shares)
48.6M
49.4M
50.3M
49.5M
Balance sheet
Nu Skin Enterprises Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$238.6M
$186.9M
$256.1M
$264.7M
Current investments
$1.2M
$11.1M
$11.8M
$13.8M
Accounts receivable, net
$39.5M
$50.8M
$72.9M
$47.4M
Inventories, net
$178.6M
$190.2M
$280.0M
$346.2M
Prepaid expenses and other
$89.7M
$72.6M
$81.2M
$87.8M
Current assets held for sale
$0
$26.9M
—
—
Total current assets
$547.7M
$538.6M
$701.9M
$759.9M
Property and equipment, net
$377.2M
$379.6M
$433.0M
$444.8M
Operating lease right-of-use assets
$74.0M
$72.6M
$90.1M
$98.7M
Goodwill
$83.6M
$83.6M
$230.8M
$206.4M
Other intangible assets, net
$42.6M
$74.3M
$105.3M
$66.7M
Other assets
$280.2M
$298.0M
$245.4M
$244.4M
Long-term assets held for sale
$0
$22.2M
—
—
Total assets
$1.4B
$1.5B
$1.8B
$1.8B
Accounts payable
$26.2M
$34.9M
$43.5M
$54.0M
Accrued expenses
$217.6M
$217.8M
$260.4M
$280.3M
Current portion of long-term debt
$20.0M
$30.0M
$25.0M
$25.0M
Current liabilities held for sale
$0
$13.9M
—
—
Total current liabilities
$263.7M
$296.6M
$328.9M
$359.2M
Operating lease liabilities
$57.6M
$58.4M
$70.9M
$76.5M
Long-term debt
$204.2M
$363.6M
$478.0M
$377.5M
Other liabilities
$74.5M
$97.5M
$106.6M
$110.4M
Long-term liabilities held for sale
$0
$1.3M
—
—
Total liabilities
$600.1M
$817.5M
$984.5M
$923.7M
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued
91.0K
91.0K
91.0K
91.0K
Additional paid-in capital
$636.0M
$627.8M
$621.9M
$613.3M
Treasury stock, at cost - 42.4 million and 40.8 million shares
-1.6B
-1.6B
-1.6B
-1.6B
Accumulated other comprehensive loss
($116.1M)
($124.8M)
($100.0M)
($86.5M)
Retained earnings
$1.9B
$1.7B
$1.9B
$1.9B
Total stockholders' equity
$805.2M
$651.5M
$822.0M
$897.3M
Total liabilities and stockholders' equity
$1.4B
$1.5B
$1.8B
$1.8B
Nu Skin Enterprises Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$189.6M
$198.7M
$251.8M
$264.2M
Current investments
$1.7M
$1.8M
$1.2M
$1.2M
Accounts receivable, net
$48.9M
$45.0M
$48.9M
$59.7M
Inventories, net
$191.5M
$178.6M
$178.5M
$180.4M
Prepaid expenses and other
$76.4M
$98.9M
$67.7M
$66.1M
Total current assets
$508.1M
$522.9M
$548.1M
$571.6M
Property and equipment, net
$379.6M
$381.6M
$375.3M
$374.2M
Operating lease right-of-use assets
$65.4M
$70.3M
$79.9M
$77.7M
Goodwill
$4.8M
$83.6M
$83.6M
$83.6M
Other intangible assets, net
$37.9M
$39.3M
$44.2M
$45.9M
Other assets
$125.8M
$279.0M
$293.2M
$290.6M
Total assets
$1.1B
$1.4B
$1.4B
$1.4B
Accounts payable
$37.7M
$28.8M
$28.5M
$28.7M
Accrued expenses
$198.6M
$208.2M
$205.9M
$220.2M
Current portion of long-term debt
$20.0M
$20.0M
$20.0M
$35.0M
Total current liabilities
$256.3M
$257.0M
$254.4M
$283.9M
Operating lease liabilities
$50.1M
$54.0M
$62.4M
$61.8M
Long-term debt
$193.7M
$203.6M
$209.0M
$213.9M
Other liabilities
$78.7M
$68.1M
$98.7M
$96.3M
Total liabilities
$578.8M
$582.7M
$624.6M
$655.9M
Class A common stock – 500 million shares authorized, $0.001 par value, 90.6 million shares issued
91.0K
91.0K
91.0K
91.0K
Additional paid-in capital
$612.4M
$613.9M
$633.2M
$627.5M
Treasury stock, at cost – 41.9 million and 42.4 million shares
-1.6B
-1.6B
-1.6B
-1.6B
Accumulated other comprehensive loss
($118.2M)
($118.4M)
($116.9M)
($114.1M)
Retained earnings
$1.6B
$1.9B
$1.8B
$1.8B
Total stockholders' equity
$542.7M
$794.1M
$799.8M
$787.8M
Total liabilities and stockholders’ equity
$1.1B
$1.4B
$1.4B
$1.4B
Cash flow statement
Nu Skin Enterprises Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income (loss)
$160.2M
($146.6M)
$8.6M
$104.8M
Gain on sale of business
($176.2M)
—
—
—
Depreciation and amortization
$52.3M
$69.8M
$70.9M
$72.5M
Non-cash lease expense
$26.2M
$26.6M
$33.3M
$44.5M
Stock-based compensation
$24.1M
$14.8M
$15.6M
$12.4M
Inventory write-down
$3.8M
$48.2M
$88.1M
—
Foreign currency losses
$6.1M
$1.7M
$1.0M
$8.2M
(Gain) loss on disposal of assets
$160.0K
($84.0K)
$780.0K
$33.0K
Impairment of fixed assets, goodwill and other intangibles
$25.1M
$181.1M
$0
$9.9M
Unrealized losses on equity investments
$28.1M
—
—
—
Deferred taxes
$20.0K
($55.5M)
($18.1M)
($51.6M)
Accounts receivable, net
$10.1M
($7.8M)
($22.7M)
($11.4M)
Inventories, net
$11.9M
$30.3M
($13.2M)
$40.3M
Prepaid expenses and other
($20.4M)
$579.0K
$6.4M
$2.8M
Other assets
($8.6M)
($1.1M)
$45.0K
$3.1M
Accounts payable
($9.1M)
($7.3M)
($10.1M)
$9.3M
Accrued expenses
($54.3M)
($27.6M)
($37.7M)
($120.8M)
Other liabilities
$858.0K
($15.5M)
($4.4M)
($15.8M)
Net cash provided by operating activities
$80.3M
$111.7M
$118.6M
$108.1M
Purchases of property and equipment
($34.3M)
($41.6M)
($58.5M)
($59.1M)
Proceeds on investment sales
$10.2M
$18.4M
$18.1M
$5.9M
Purchases of investments
$0
($14.8M)
($16.9M)
($14.0M)
Acquisitions (net of cash acquired)
$0
$0
($77.3M)
$0
Proceeds from sale of business, net
$193.7M
—
—
—
Other, net
$1.0M
—
—
—
Net cash provided by (used in) investing activities
$170.7M
($38.0M)
($134.5M)
($67.1M)
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards
-1.9M
-2.1M
4.6M
27.1M
Payment of cash dividends
($11.8M)
($11.9M)
($77.6M)
($77.0M)
Repurchase of shares of common stock
-20.0M
0
-13.0M
-70.0M
Finance lease principal payments
($2.2M)
($2.9M)
($3.2M)
($1.9M)
Contingent consideration payments
$0
($6.3M)
—
—
Payments on debt
($225.0M)
($125.0M)
($10.0M)
($432.5M)
Proceeds from debt
$55.0M
$15.0M
$110.0M
$460.0M
Other, net
$3.6M
—
—
—
Net cash (used in) provided by financing activities
($202.4M)
($133.2M)
$10.7M
($99.5M)
Effect of exchange rate changes on cash
$3.2M
($9.8M)
($3.5M)
($16.3M)
Net increase (decrease) in cash and cash equivalents
$51.7M
($69.2M)
($8.7M)
($74.9M)
Cash and cash equivalents, beginning of period
$186.9M
$256.1M
$264.7M
$339.6M
Cash and cash equivalents, end of period
$238.6M
$186.9M
$256.1M
$264.7M
Nu Skin Enterprises Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income (loss)
($248.0M)
$1.8M
$145.7M
$128.6M
Gain on sale of business
$0
$0
($176.2M)
($176.2M)
Impairment of goodwill, fixed assets and other intangibles
$80.7M
$1.8M
$25.1M
$25.1M
Unrealized losses on equity investments
$0
$0
$28.1M
$28.1M
Depreciation and amortization
$25.0M
$12.3M
$39.3M
$27.3M
Non-cash lease expense
$12.5M
$6.5M
$19.5M
$13.1M
Stock-based compensation
$4.8M
$3.7M
$20.9M
$15.1M
Inventory write-down
$6.1M
$4.8M
$5.8M
$5.8M
Foreign currency losses (gains)
($254.0K)
($1.4M)
$4.5M
$2.4M
Loss (gain) on disposal of assets
$293.0K
$303.0K
$171.0K
($72.0K)
Deferred taxes
$166.0M
$1.7M
($8.2M)
($6.8M)
Accounts receivable, net
($10.0M)
($5.7M)
$1.3M
($8.7M)
Inventories, net
($21.3M)
($5.9M)
$11.0M
$10.9M
Prepaid expenses and other
$12.7M
($9.1M)
$1.6M
$6.3M
Other assets
($4.3M)
$199.0K
($9.5M)
($7.4M)
Accounts payable
$11.7M
$2.8M
($6.9M)
($6.8M)
Accrued expenses
($30.3M)
($14.7M)
($41.1M)
($20.3M)
Other liabilities
$987.0K
($3.0M)
$2.4M
($280.0K)
Net cash provided by operating activities
$6.7M
($3.9M)
$63.7M
$36.2M
Purchases of property and equipment
($19.4M)
($13.7M)
($23.5M)
($13.6M)
Purchases of investments
($573.0K)
($573.0K)
$0
$0
Proceeds on investment sales
$0
$0
$10.2M
$10.2M
Proceeds from sale of business, net
$0
$0
$193.7M
$193.7M
Net cash (used in) provided by investing activities
($19.9M)
($14.3M)
$180.4M
$190.3M
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards
-4.1M
-4.2M
-1.2M
-1.1M
Payment of cash dividends
($5.8M)
($2.9M)
($8.9M)
($6.0M)
Repurchases of shares of common stock
-5.0M
-5.0M
-10.0M
-5.0M
Finance lease principal payments
($978.0K)
($489.0K)
($1.8M)
($1.1M)
Proceeds from debt
$225.0M
$225.0M
$55.0M
$15.0M
Payments of debt
($235.0M)
($225.0M)
($220.0M)
($160.0M)
Payment of debt issuance costs
($1.4M)
($1.4M)
—
—
Purchase of noncontrolling interest
($6.5M)
($6.5M)
—
—
Net cash used in financing activities
($33.8M)
($20.4M)
($183.9M)
($157.0M)
Effect of exchange rate changes on cash
($2.0M)
($1.4M)
$4.7M
$7.8M
Net (decrease) increase in cash and cash equivalents